Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

In this Healio Video Perspective from Telling It Like It Is, Cynthia Matossian, MD, FACS, shared pearls for ophthalmologists ...

In the post-op SAKK 09/10 trial, only patients in the higher PORTOS score group benefited from radiation therapy dose escalation (clinical progression free survival HR 0.19, 95% CI 0.05-0.70; p = 0.01 ...

The preventive duration requires individualised adjustment by clinicians based on the patient’s condition, undeniably complicating clinical management. Based on current guidelines and expert consensus ...

Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Vaxcyte has advanced to the Phase II trial’s second and final stage (Stage 2) assessing its 31-valent pneumococcal conjugate ...

accounted for 18% of the total sample size in the Phase 2 study. A consistent top-enroller in acute schizophrenia clinical trials, Segal Trials contributed to the study sample size with a rate of ...

A$AP Rocky arrives at Superior Court of Los Angeles for his gun assault trial on Jan. 21, 2025. (DUTCH/Bauer-Griffin/GC Images) ...

The trial in Duke of Sussex’s long-running case against the Rupert Murdoch-owned 'The Sun' newspaper was set to begin in London on Jan. 21 Simon Perry is a writer and correspondent at PEOPLE.

She has covered celebrity deaths, lawsuits, and the Hunter Biden gun trial. Erin joined Newsweek in 2024 from the New York Post and had previously worked at News Center Maine. She is a graduate of ...